BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

BACKGROUND: In breast cancer, BRCA promoter hypermethylation and BRCA germline mutations are said to occur together rarely, but this property has not yet been translated into a clinical test. Our aim in this study was to investigate the diagnostic value of BRCA1/2 methylation in distinguishing breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Shoko, Moelans, Cathy Beatrice, van Diest, Paul Joannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452400/
https://www.ncbi.nlm.nih.gov/pubmed/28569220
http://dx.doi.org/10.1186/s13058-017-0856-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452400/
https://www.ncbi.nlm.nih.gov/pubmed/28569220
http://dx.doi.org/10.1186/s13058-017-0856-z

Ejemplares similares